ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 211 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $278,236 | -16.3% | 647 | -23.3% | 0.00% | – |
Q1 2024 | $332,300 | -0.9% | 844 | -4.2% | 0.00% | – |
Q4 2023 | $335,159 | -93.4% | 881 | -93.5% | 0.00% | -100.0% |
Q1 2023 | $5,060,755 | -61.3% | 13,583 | -60.7% | 0.01% | -61.5% |
Q4 2022 | $13,085,546 | +7.3% | 34,542 | +0.0% | 0.01% | 0.0% |
Q3 2022 | $12,193,000 | -6.8% | 34,535 | +0.1% | 0.01% | 0.0% |
Q2 2022 | $13,077,000 | +27.6% | 34,517 | +6.2% | 0.01% | +44.4% |
Q1 2022 | $10,251,000 | -10.0% | 32,510 | -0.0% | 0.01% | 0.0% |
Q4 2021 | $11,384,000 | +977.0% | 32,512 | +195.6% | 0.01% | +800.0% |
Q4 2018 | $1,057,000 | – | 11,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 78,138 | $12,543,000 | 7.60% |
Redmile Group, LLC | 1,153,232 | $185,117,000 | 4.43% |
Avoro Capital Advisors LLC | 936,500 | $150,327,000 | 4.41% |
MPM BioImpact LLC | 71,700 | $11,509,000 | 4.08% |
AWM Investment Company, Inc. | 95,000 | $15,249,000 | 2.98% |
EcoR1 Capital, LLC | 202,117 | $32,444,000 | 2.92% |
INDUS CAPITAL PARTNERS, LLC | 79,095 | $12,696,000 | 2.49% |
Bellevue Group AG | 967,989 | $156,070,000 | 2.47% |
DCF Advisers, LLC | 22,000 | $3,531,000 | 2.24% |
Dorsey Wright & Associates | 41,416 | $6,648,000 | 2.20% |